REPLIGEN CORPRGEN

Market cap

$8.9B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	11	29	40	35	54	122	174	194	537	717	604	524	751	757
Marketable securities, current	15	11	44	23	18	20	-	-	-	-	-	-	-	-
Total cash & short-term investments	27	40	83	58	72	142	174	194	537	717	604	524	751	757
Accounts receivable, net	3	4	5	8	11	15	28	33	43	71	117	116	124	134
Inventories	13	11	12	12	18	25	39	42	55	95	184	238	202	143
Total current assets	47	66	86	81	103	184	243	276	642	902	932	998	1,111	1,066
Property, plant and equipment, net	11	10	13	15	14	15	22	32	48	67	125	191	207	198
Marketable securities, non-current	9	10	12	4	2	-	-	-	-	-	-	-	-	-
Total non-current assets	29	31	32	47	43	105	501	499	758	1,001	1,427	1,527	1,713	1,764
Total assets	76	97	119	128	146	289	744	775	1,400	1,903	2,358	2,525	2,824	2,830
Accounts payable	1	2	2	4	7	5	7	10	11	17	36	28	20	32
Total current liabilities	7	11	11	11	19	21	25	130	48	319	375	404	158	127
Total non-current liabilities	-	-	-	-	-	-	-	29	292	55	233	210	695	730
Total liabilities	-	-	-	-	-	-	-	159	340	374	608	614	853	857
Common stock and paid-in capital	185	187	191	328,000	0	0	0	0	1	1	1	1	1	1
Retained earnings	-119,306,614	-105,150,577	-89,057,422	-80,887,208	-72	-60	-32	-16	6	66	194	397	439	407
Stockholders' equity	66	84	104	112	123	169	592	616	1,060	1,529	1,750	1,911	1,971	1,973
Working capital